Page 135 - Pagetit
P. 135

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Fowler JS et al. (2001) [(11)] Cocaine: PET studies of cocaine pharmacokinetics,
                   dopamine transporter availability and dopamine transporter occupancy. Nuclear
                   Medicine and Biology, 28:561–572.
                   Fox BS et al. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models.
                   Nature Medicine, 2:1129–1132.
                   French ED (1997) Delta 9-tetrahydrocannabinol excites rat VTA dopamine
                   neurons through activation of cannabinoid CB1 but not opioid receptors.
                   Neuroscience Letters, 226:159–162.
                   Galiegue S et al. (1995) Expression of central and peripheral cannabinoid
                   receptors in human immune tissues and leukocyte subpopulations. European
                   Journal of Biochemistry, 232:54–61.
                   Gessa GL et al. (1985) Low doses of ethanol activate dopaminergic neurons in
                   the ventral tegmental area. Brain Research, 348:201–203.
                   Gessa GL et al. (1998) Cannabinoids activate mesolimbic dopamine neurons by
                   an action on cannabinoid CB1 receptors. European Journal of Pharmacology,
                   341:39–44.
                   Glick SD, Weaver LM, Meibach RC (1980) Lateralization of reward in rats:
                   differences in reinforcing thresholds. Science, 207:1093–1095.
                   Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humans
                   and experimental animals responding under intermittent schedules of IV drug
                   injection. Pharmacology, Biochemistry and Behavior, 30:227–234.
                   Goldberg SR et al. (1983) Control of behavior by intravenous nicotine injections
                   in laboratory animals. Pharmacology, Biochemistry and Behavior, 19:1011–1020.
                   Gomez TH, Roache JD, Meisch RA (2002) Orally delivered alprazolam, diazepam,
                   and triazolam as reinforcers in rhesus monkeys. Psychopharmacology (Berlin),
                   161:86–94.
                   Grahame NJ et al. (2001) Alcohol place preference conditioning in high- and low-
                   alcohol preferring selected lines of mice. Pharmacology, Biochemistry and
                   Behavior, 68:805–814.
                   Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans
                   and laboratory animals: implications for problems of long-term use and abuse.
                   Psychopharmacology (Berlin), 134:1–37.
                   Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human
                   drug-taking behavior. In: Mello NK, ed. Advances in substance abuse. Greenwich,
                   CT, JAI Press:1–90.
                   Grispoon L, Bakalar J (1986) Can drugs be used to enhance the psychotherapeutic
                   process? American Journal of Psychotherapeutics, 40:393–404.
                   Grobin AC et al. (1998) The role of GABA(A) receptors in the acute and chronic
                   effects of ethanol. Psychopharmacology, 139:2–19.

                   Haefly WE (1978) Central action of benzodiazepines: general introduction. British
                   Journal of Psychiatry, 133:231–238.
                   Hanus L et al. (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the
                   cannabinoid CB1 receptor. Proceedings of the National Academy of Science of the
                   United States of America, 98:3662–3665.


                                                  114




          Chapter_4                114                             19.1.2004, 11:44
   130   131   132   133   134   135   136   137   138   139   140